Src相关血小板减少症:巨核细胞功能障碍与免疫介导疾病之间的细微界限
本文报告一个携带Src p.E527K变异的三代家系,患者表现为血小板计数波动(38-139×10^9/L)、血小板功能轻度受损、未成熟血小板比例>15%及大血小板增多;4例成人曾被诊断为免疫性血小板减少症(ITP)并接受脾切除术,术后血小板持续>75×10^9/L数年,糖皮质激素治疗后血小板亦升高。7例变异携带者中4例存在免疫缺陷和反复感染,部分成员出现神经系统症状。患者血小板存在Src、布鲁顿酪氨酸激酶和磷脂酶Cγ2组成性激活。
要点
- SRC-RT由Src p.E527K杂合胚系功能获得性变异引起,呈常染色体显性遗传。
- 患者血小板计数波动于38-139×10^9/L,未成熟血小板比例>15%,可见大量大血小板。
- 4例成人曾被诊断为ITP并接受脾切除术,术后血小板持续>75×10^9/L数年。
核心结论
- SRC-RT除导致血小板生成受损外,还可能伴随免疫失调和血小板消耗增加。
- 对于多个家庭成员对ITP治疗有反应的家族,应排除潜在的Src p.E527K变异。
研究设计与样本
- 本文报告一个携带Src p.E527K变异的三代家系。
- 迄今该病的基因诊断仅报道于3个无关家族的7例患者。
主要发现
- 患者血小板计数波动于38-139×10^9/L,血小板功能轻度受损,未成熟血小板比例>15%,大血小板比例显著。
- 4例成人曾被诊断为ITP并接受脾切除术,术后血小板持续>75×10^9/L数年;糖皮质激素治疗后血小板亦升高。
- 7例Src p.E527K变异携带者中4例存在免疫缺陷和反复感染;部分家庭成员出现从特定语言障碍到癫痫的神经系统症状。
- 患者血小板存在Src、布鲁顿酪氨酸激酶和磷脂酶Cγ2组成性激活;交联表面免疫球蛋白M刺激CD19细胞后,携带Src p.E527K个体的B细胞中磷酸化细胞外信号调节激酶显著增加。
临床怎么用
- 对于多个家庭成员对ITP导向治疗有反应的家族,应排除潜在的Src p.E527K变异。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Src-related thrombocytopenia (SRC-RT) is a rare autosomal dominant, inherited platelet disorder resulting from the p.E527K heterozygous germline gain-of-function variant of Src. To date, genetic diagnosis of the disease has only been reported in 7 patients from 3 unrelated families. The clinical features ranged from isolated thrombocytopenia to complex syndromic manifestations characterized by thrombocytopenia, bleeding, myelofibrosis, splenomegaly, and bone disease. We report a new 3-generation kindred with the Src p.E527K variant. Patients presented with rather variable platelet counts (38-139 × 109/L), mildly impaired platelet function, >15% immature platelet fraction, and with a significant proportion of large-giant platelets. Four adults from the family were diagnosed with immune thrombocytopenia (ITP) and underwent splenectomy, achieving sustained platelet counts >75 × 109/L for several years; increases in platelet counts were also observed after corticosteroid therapy. Four of 7 Src p.E527K variant carriers showed immune defects and recurrent infections. In addition, a range of neurological symptoms, from specific language impairment to epilepsy, was seen in some family members. Patient platelets exhibited constitutive Src, Bruton tyrosine kinase, and phospholipase Cγ2 activation, and after stimulating CD19 cells by crosslinking surface immunoglobulin M, phosphorylated extracellular signal-regulated kinase (ERK) was significantly increased in B cells from individuals carrying the Src p.E527K substitution. In summary, in addition to causing impaired platelet production, SRC-RT may associate immune dysregulation and increased platelet consumption. In families in whom several members are responsive to ITP-directed therapies, an underlying Src p.E527K variant should be excluded.
引用
- Palma-Barqueros V, Revilla N, Zaninetti C, et al. Src-related thrombocytopenia: a fine line between a megakaryocyte dysfunction and an immune-mediated disease. Blood Adv. 2022. PMID: 35349645. doi:10.1182/bloodadvances.2021005446
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。